Author:
Long Dan,Yu Ting,Chen Xian,Liao Ying,Lin Xuechi
Funder
National Natural Science Foundation of China
Key Project of Hunan Province Scientific Research of Colleges and Universities
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Cell Biology,Toxicology
Reference40 articles.
1. Akhtar J, Wang Z, Yu C, Li CS, Shi YL, Liu HJ. STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells. BMC Cancer. 2014;14:28.
2. Armat M, Oghabi Bakhshaiesh T, Sabzichi M, Shanehbandi D, Sharifi S, Molavi O, et al. The role of Six1 signaling in paclitaxel-dependent apoptosis in MCF-7 cell line. Bosn J Basic Med Sci/ Udruzenje basicnih mediciniskih znanosti = Assoc Basic Med Sci. 2016;16:28–34.
3. Barve M, Wang Z, Kumar P, Jay CM, Luo X, Bedell C, et al. Phase 1 trial of bi-shRNA STMN1 BIV in refractory cancer. Mol Ther. 2015;23:1123–30.
4. Bocci G, Di Paolo A, Danesi R. The pharmacological bases of the antiangiogenic activity of paclitaxel. Angiogenesis. 2013;16:481–92.
5. El Benna H, Zribi A, Laabidi S, Haddaoui A, Mlika M, Skhiri H, et al. Ki-67: role in diagnosis, prognosis and follow-up after treatment of breast cancers. La Tunisie medicale. 2015;93:737–41.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献